Platelet Drugs and Antocoagulants

Antiplatelet drugs decrease platelet aggregation and inhibit thrombus formation while anticoagulants are blood thinners that prolong clotting time. Both agents are amongst the most commonly used medications to reduce coagulation.

January 14, 2021
Open Access

A case report of arterial and venous thromboembolism in a patient with severe COVID-19 pneumonia

European Heart Journal. Case Reports
Samuel Del Castillo-GarcíaFelipe Fernández-Vázquez
January 13, 2021

Pulmonary thromboembolism in coronavirus disease 2019 patients undergoing thromboprophylaxis

Simone SchiaffinoFrancesco Sardanelli
January 15, 2021

Host fibrinogen drives antimicrobial function in Staphylococcus aureus peritonitis through bacterial-mediated prothrombin activation

Proceedings of the National Academy of Sciences of the United States of America
Joni M PrasadMatthew J Flick
January 14, 2021
Open Access

Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival

Journal for Immunotherapy of Cancer
Tamara A SussmanAlok A Khorana
January 14, 2021
Open Access

Incidence, prognostic factors, and outcomes of venous thromboembolism in critically ill patients: data from two prospective cohort studies

Critical Care : the Official Journal of the Critical Care Forum
Ruben J EckFrederik Keus
January 15, 2021

Anticoagulation and antiplatelet therapy in contact sports: is it career limiting?

Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
Asim KichlooDavid Rechlin
January 15, 2021

Long-Term Safety and Efficacy of Antiplatelet Therapy in Patients With Cerebral Infarction With Thrombocytopenia

Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Shijie GuoGuilin Meng
January 14, 2021

Non-Vitamin K Antagonist Oral Anticoagulant vs Warfarin for Post Cardiac Surgery Atrial Fibrillation

The Annals of Thoracic Surgery
Victor NauffalPatrick T Ellinor
January 13, 2021
Open Access

Validation of an HPLC-MS/MS Method for the Determination of Plasma Ticagrelor and Its Active Metabolite Useful for Research and Clinical Practice

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Jennifer Lagoutte-RenosiSiamak Davani
January 14, 2021

The swedish covid-19 intensive care cohort: risk factors of icu admission and icu mortality

Acta Anaesthesiologica Scandinavica
Björn AhlströmMiklos Lipcsey
January 13, 2021

Clinical characteristics and stratification of the cerebrovascular accident risk among patients with atrial fibrillation in Colombia, 2011-2016

Expert Review of Cardiovascular Therapy
Diego Alejandro Medina-MoralesJorge Enrique Machado-Alba
January 15, 2021

Retrospective Review of Prescribing Patterns in Cancer-Associated Thrombosis: A Single Center Experience in Edmonton, Alberta, Canada

Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Hannah KalielTammy J Bungard
January 14, 2021
Open Access

Evaluation of the initial response in clinical trial efforts for COVID-19 in Brazil

Revista brasileira de epidemiologia = Brazilian journal of epidemiology
Tatiane Bomfim RibeiroDaniela Oliveira de Melo

Sign up to follow this feed and discover related papers.

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Coagulation Products

Coagulation products used to manage bleeding in patients with these disorders include AHF concentrates, factor IX concentrates, factor VIIa concentrate, factor IX complexes, anti-inhibitor coagulant complexes, and desmopressin acetate. Discover the latest research on coagulation products here.

Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.


Immuno-oncology (or cancer immunotherapy) is the artificial stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight cancer. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules. Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill. Discover the latest research on immuno-oncology here.

Immunomodulating Agents

Immunomodulating agents are substances that stimulate or suppresse the immune system and may help the body combat againsts cancer, infection, or other diseases. Discover the latest research on immunomodulating agents here.

Metastatic Malignancy Treatments

Treatment of metastatic cancers depends on the type of cancer and the severity of the disease. The regime often includes medications such as chemotherapy or hormone therapy, but may also include immunotherapy, radiation therapy, surgery or a combination. Discover the latest research on metastatic cancer treatments here.

Pharmacological Treatment of Allergies

Allergies, also known as allergic diseases, are a number of conditions caused by hypersensitivity of the immune system to typically harmless substances in the environment. There are various pharmacological treatments for allergy including antihistamines, anti-cholinergics, decongestants, etc. Discover the latest research on pharmacological treatment of allergies here.

© 2021 Meta ULC. All rights reserved